ICECURE MEDICAL ($ICCM) posted quarterly earnings results for Q2 2026 on Wednesday, August 12th. The company reported earnings of -$3.11 per share, missing estimates of -$1.53 by $1.58. The company also reported revenue of $910,000, missing estimates of $1,479,336 by $-569,336.
You can see Quiver Quantitative's $ICCM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ICECURE MEDICAL Hedge Fund Activity
We have seen 7 institutional investors add shares of ICECURE MEDICAL stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 2,712,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $816,312
- JANE STREET GROUP, LLC removed 109,638 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $33,001
- CONCURRENT INVESTMENT ADVISORS, LLC removed 78,285 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $380,465
- WARBERG ASSET MANAGEMENT LLC removed 65,568 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $318,660
- VIRTU FINANCIAL LLC removed 64,524 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $19,421
- UBS GROUP AG added 62,033 shares (+67.3%) to their portfolio in Q1 2026, for an estimated $18,671
- HRT FINANCIAL LP added 32,247 shares (+210.1%) to their portfolio in Q1 2026, for an estimated $9,706
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
